Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block
Autor: | Yuxian Chen, Jibing Chen, Jialiang Li, Kecheng Xu, Lizhi Niu, Jian-Sheng Zuo, Fei Yao, Changqun Wei, Yu’e Wang, Li Zhang |
---|---|
Rok vydání: | 2013 |
Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Celiac plexus Celiac Plexus urologic and male genital diseases Cryosurgery Gastroenterology General Biochemistry Genetics and Molecular Biology Internal medicine Pancreatic cancer medicine Humans Pancreas Aged Retrospective Studies Aged 80 and over business.industry Cancer Visceral pain Cryoablation Visceral Pain General Medicine Middle Aged Abdominal distension medicine.disease Surgery Pancreatic Neoplasms medicine.anatomical_structure Female medicine.symptom General Agricultural and Biological Sciences business Cancer pain Autonomic Nerve Block |
Zdroj: | Cryobiology. 66:105-111 |
ISSN: | 0011-2240 |
DOI: | 10.1016/j.cryobiol.2012.12.002 |
Popis: | Little is known about the effects of pancreas cryoablation (PCA) on abdominalgia in pancreatic cancer patients or its synergism with celiac plexus block (CPB). In patients without abdominalgia, to investigate the effects of PCA; in patients with abdominalgia, to investigate the pain-alleviating effects of PCA+CPB. Sixty-two patients were enrolled in this retrospective review; 12 without abdominalgia refused PCA, 15 without abdominalgia received PCA to reduce their tumor load and 35 with abdominalgia received PCA+CPB to reduce tumor load and alleviate pain. All PCA and PCA+CPB procedures were performed successfully. Some slight adverse effects (e.g. increased serum amylase, abdominal distension and nausea, abdominal bleeding) had disappeared by 3weeks, spontaneously or after symptomatic treatment. In patients without abdominalgia, pain occurred in one-third of cases (all with pancreatic head cancer) after PCA but had stopped 1-12days after treatment; in patients with abdominalgia before treatment, pain stopped immediately after PCA+CPB in 18 cases and 2-24days after treatment in 17 (all with pancreatic head cancer); a significant difference was found between pretreatment and post-treatment pain frequency (P=0.0019), regardless of the presence of advanced (P=0.0096) or metastatic (P=0.0072) cancer. The average time to pain relief was approximately 7days after both PCA and PCA+CPB, and abdominalgia did not recur for more than 8weeks. PCA may cause short-term pain in some pancreatic cancer patients. Combined PCA+CPB can alleviate cancer pain for more than 8weeks, without severe side effects. |
Databáze: | OpenAIRE |
Externí odkaz: |